(amlodipine besylate + hydrochlorothiazide + valsartan)
Marketedupdated 2mo agoby $NVS NOVARTIS AG
Approvedcommunity read0 votes
indications
investigational
Hypertension
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that